| HOME >> MEDICINE >> TECHNOLOGY |
4.3.2 NICHE THERAPEUTIC AREAS
4.3.3 WELLNESS PRODUCTS
5 TIME RELEASE TECHNOLOGY
5.1 DRIVERS
5.1.1 TIME RELEASE FORMULATIONS IN KEY THERAPEUTIC AREAS
5.1.2 ONCE-A-DAY FORMULATIONS
5.1.3 COST EFFECTIVE
5.2 RESTRAINTS
5.2.1 LIMITED NUMBER OF MATERIALS
5.2.2 TECHNICAL BARRIERS
5.3 OPPORTUNITIES
5.3.1 PARTICULATE AND CHRONOPHARMACOKINETIC SYSTEMS
5.3.2 MUCOADHESIVE DRUG DELIVERY
5.4 BIODEGRADABLE POLYMERS
5.5 MULTIPARTICULATE BEAD SYSTEMS
5.6 MATRIX SYSTEMS
5.7 REGULATORY ENVIRONMENT
5.8 TIMED RELEASE VS IMMEDIATE RELEASE FORMULATIONS
5.9 INNOVATIONS IN TIME RELEASE TECHNOLOGIES
5.1 INDUSTRY INSIGHTS
5.11 WINNING IMPERATIVES
5.12 COMPETITIVE DEVELOPMENTS
6 TARGETED DELIVERY
6.1 DRIVERS & RESTRAINTS
6.1.1 INCREASED DEMAND FOR TREATMENT OF CANCEROUS TUMORS
6.1.2 LACK OF TARGETED DRUG DELIVERY TECHNOLOGIES FOR TREATMENT OF BRAIN TUMOR
6.1.3 HIGH COST OF TARGETED ANTIBODY-BASED CANCER THERAPEUTICS
6.2 OPPORTUNITY
6.2.1 NOVEL TARGETED DRUG DELIVERY SYSTEMS
6.3 TARGETING LIGANDS
6.4 NON-BIOLOGICAL TARGETING PLATFORMS
6.5 TYPES OF TARGETED THERAPIES & COMPANY FOCUS
6.6 IMPACT OF TARGETED DRUG DELIVERY IN CANCER & OTHER CHRONIC CONDITIONS
6.7 INNOVATIONS
6.8 INDUSTRY INSIGHTS
6.9 WINNING IMPERATIVES
7 ENCAPSULATION TECHNOLOGIES
7.1 DRIVERS & RESTRAINTS
7.1.1 ENHANCED BIOAVAILABILITY
7.1.2 EXTENSIVE USAGE IN TASTE MASKING AND FASTER DISSOLVING PILLS
7.1.3 ECONOMICALLY FEASIBLE
7.1.4 RELUCTANCE IN INVESTING IN NOVEL TECHNOLOGIES
7.2 OPPORTUNITY
7.2.1 SOPHISTICATED MICROENCAPSULATION SYSTEMS
7.3 MICROENCAPSULATION
7.4 NANOENCAPSULATION
7.5 EVOLUTION OF ENCAPSULATION TECHNOLOGIES
7.6 APPLICATION OF ENCAPSULATION
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |